PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma
NCT00472043
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Basal Cell Carcinoma
Interventions
DRUG:
PDT with Metvix 160 mg/g cream
DRUG:
Placebo
Sponsor
Galderma R&D